"And the company has not even started the US pilot study yet." is an over concern. OSL has made a head start already.
ASX Announcement 31 January 2019
Quarterly Activities & Cash Flow Report
Quarter ended 31 December 2018
OncoSil’s US OncoPaC-1 clinical study has now closed for recruitment with 9 patients successfully implanted.
Anyone Left?, page-54
-
- There are more pages in this discussion • 137 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add OSL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
1.1¢ |
Change
0.001(10.0%) |
Mkt cap ! $41.62M | |||
| Open | High | Low | Value | Volume |
| 1.1¢ | 1.1¢ | 1.0¢ | $34.82K | 3.319M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 7 | 6856710 | 1.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 1.1¢ | 2741527 | 4 |
View Market Depth
| Last trade - 16.10pm 09/08/2024 (20 minute delay) ? |
| OSL (ASX) Chart |